Veranex
↗Raleigh, USA
Veranex is a global, integrated product development and commercialization partner dedicated to the medical technology (MedTech) and biopharma industries. The company operates as an 'Innovation CRO' (iCRO), providing a comprehensive 'concept-to-commercialization' platform that unites product design, engineering, preclinical research, clinical trials, regulatory strategy, and market access under a single entity.
Formed in 2021 through the merger of several industry leaders and backed by Summit Partners, Veranex aims to accelerate the development of life-saving medical innovations while reducing costs and regulatory risks. The company serves a diverse range of clients, from early-stage startups to large multinational strategics, across therapeutic areas such as cardiovascular, neurology, and oncology.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$500M
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$100M+
Investors:Summit Partners, Accelmed, Lauxera Capital Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Medical Devices, In-Vitro Diagnostics, Digital Health, Combination Products, Software as a Medical Device (SaMD)
Active Trials:2500
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Ximedica, Quartesian, Boston Healthcare Associates, Medidee, Devicia, Clarvin, Horus Scientific, Fusion Biotec, Worrell, T3 Labs
Key Partnerships:Stanford Byers Center for Biodesign (Sponsor), Summit Partners (Strategic Growth Partner)
COMPETITION
Position:Leader
Competitors:IQVIA (MedTech Division), NAMSA, MCRA, Avania, Medpace, Syneos Health, ICON plc, ProPharma Group
LEADERSHIP
Key Executives:
Lisa Boyle - Interim CEO & Chief Innovation Officer
David Dockhorn - Chief Operating Officer
Jose Pablo Morales, MD - Chief Medical Officer
Board Members:Darren M. Black (Executive Chairman), David Adair, M.D., Patrick K. Donnelly, Uri Geiger, Ph.D., Samuel Levy
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Veranex. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.